Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 024980/0370 | |
| Pages: | 25 |
| | Recorded: | 09/14/2010 | | |
| Attorney Dkt #: | 52598-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/22/2013
|
Application #:
|
12922213
|
Filing Dt:
|
09/13/2010
|
|
Publication #:
|
|
Pub Dt:
|
01/27/2011
| | | | |
|
Title:
|
CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS
|
|
|
Assignee
|
|
|
|
|
| LICHTSTRASSE 35 |
| BASEL, SWITZERLAND 4056 |
|
|
Correspondence name and address
|
| |
LINDA ADAMS
|
| |
NOVARTIS PHARMACEUTICALS CORP.
|
| |
ONE HEALTH PLAZA
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
06/19/2024 08:10 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
